|
PHTF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.575900E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.441000E-01 |
| Normal-vs-Stage2 |
3.433400E-01 |
| Normal-vs-Stage3 |
1.928480E-02 |
| Normal-vs-Stage4 |
4.187800E-02 |
| Stage1-vs-Stage2 |
9.280200E-01 |
| Stage1-vs-Stage3 |
1.616990E-01 |
| Stage1-vs-Stage4 |
2.208000E-01 |
| Stage2-vs-Stage3 |
3.078400E-01 |
| Stage2-vs-Stage4 |
2.908200E-01 |
| Stage3-vs-Stage4 |
8.992200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.927700E-02 |
| Normal-vs-AfricanAmerican |
8.300800E-01 |
| Normal-vs-Asian |
5.307600E-02 |
| Caucasian-vs-AfricanAmerican |
1.535380E-01 |
| Caucasian-vs-Asian |
7.935800E-01 |
| AfricanAmerican-vs-Asian |
1.293980E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.128400E-01 |
| Normal-vs-Female |
2.015600E-02 |
| Male-vs-Female |
3.354600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.053400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.132040E-02 |
| Normal-vs-Age(61-80Yrs) |
7.965800E-02 |
| Normal-vs-Age(81-100Yrs) |
4.105600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.952500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.352800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.137200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.883200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.682600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.928400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.258200E-02 |
| Classical-VS-Follicular |
7.694800E-01 |
| Classical-VS-Other |
2.433600E-01 |
| Classical-VS-Normal |
1.451770E-01 |
| Tall-VS-Follicular |
7.403800E-02 |
| Tall-VS-Other |
9.452800E-01 |
| Tall-VS-Normal |
1.482240E-03 |
| Follicular-VS-Other |
3.724200E-01 |
| Follicular-VS-Normal |
1.968360E-01 |
| Other-VS-Normal |
2.821800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.341590E-02 |
| Normal-vs-N1 |
9.103800E-03 |
| N0-vs-N1 |
3.432400E-01 |
|
|
